Education
About Us
Working with TipRanks
Follow Us
MediPress Health-Limited Partnership Partnership Units (IL:MPRS)
:MPRS
MPRS Stock Chart & Stats
Day’s Range― - ―
52-Week Range58.30 - 93.80
Previous CloseN/A
Volume459.00
Average Volume (3M)1.32K
Market Cap
9.31M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.56
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding15,012,000
10 Day Avg. Volume1,157
30 Day Avg. Volume1,319
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
MediPress Health-Limited Partnership Partnership Units News
PremiumCompany Announcements
MediPress Health Sees Increase in Stakeholder Holdings
PremiumCompany Announcements
MediPress Health Reports Change in Securities Holdings---
MPRS FAQ
What was MediPress Health-Limited Partnership Partnership Units’s price range in the past 12 months?
MediPress Health-Limited Partnership Partnership Units lowest stock price was 58.30 and its highest was 93.80 in the past 12 months.
What is MediPress Health-Limited Partnership Partnership Units’s market cap?
MediPress Health-Limited Partnership Partnership Units’s market cap is 9.31M.
When is MediPress Health-Limited Partnership Partnership Units’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MediPress Health-Limited Partnership Partnership Units’s earnings last quarter?
Currently, no data Available
Is MediPress Health-Limited Partnership Partnership Units overvalued?
According to Wall Street analysts MediPress Health-Limited Partnership Partnership Units’s price is currently Overvalued.
Does MediPress Health-Limited Partnership Partnership Units pay dividends?
MediPress Health-Limited Partnership Partnership Units does not currently pay dividends.
What is MediPress Health-Limited Partnership Partnership Units’s EPS estimate?
MediPress Health-Limited Partnership Partnership Units’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MediPress Health-Limited Partnership Partnership Units have?
MediPress Health-Limited Partnership Partnership Units has 15,012,000 shares outstanding.
What happened to MediPress Health-Limited Partnership Partnership Units’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of MediPress Health-Limited Partnership Partnership Units?
Currently, no hedge funds are holding shares in IL:MPRS
---
Company Description
MediPress Health-Limited Partnership Partnership Units
MediPress Health-Limited Partnership, is a research and development life science partnership and venture capital firm specializing in seed/startups investments. The firm seeks to invest in medical research and development companies. Its portfolio companies engage in the treatment of cancer with proton radiation therapy; and the development of non-surgical vaginal solutions for women with various pelvic floor disorders. The firm seeks to take board positions in its portfolio companies. MediPress Health-Limited Partnership was incorporated in 2021 and is based in Ramat Gan, Israel.
---
Technical Analysis
---